2m 2m 2m 2m 2m 2m 2m
Abbott Laborator (ABT)
NYSE
$103.25+$0.74 (+0.72%)
Price as of Oct 22, 2026 7:59 PM EDT- $173.9BMarket Cap
- -19.49%1-Year Change
- Medical DevicesIndustry
Abbott Laborator (ABT)
$103.25+$0.74 (+0.72%)
ABT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $102.51 | ||
Change | -$1.94 (-1.89%) | ||
Open | $101.50 | ||
High | $102.90 | ||
Low | $99.91 | ||
Previous Close | $100.51 | ||
Volume | 10,661,558 | ||
30-Day Average Volume | 9,674,704 | ||
1-Week Change | -1.79% | ||
1-Month Change | -1.80% | ||
1-Year Change | -19.49% | ||
3-Year Change | 10.62% | ||
5-Year Change | -11.21% | ||
Fundamentals | |||
Shares Outstanding | 1.7B | ||
Total Assets | $109.2B | ||
Market Cap | $173.9B | ||
Enterprise Value | $201.4B | ||
Period: QTR TTM FY | |||
Revenue | $12.6B | ||
Net Income | $928.0M | ||
Free Cash Flow | $2.0B | ||
EBIT | $1.8B | ||
EBITDA | $2.5B | ||
Net Working Capital | $6.7B | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 81 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 3 | ||
P/E | 190 | ||
PEG | -14 | ||
Price/Free Cash Flow | 87 | ||
Price/Operating Cash Flow | 70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.51% | ||
Trailing Annual Dividend Yield | 2.51% | ||
Ex-Dividend Date | 10/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield